C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/12 (2006.01) A61K 39/395 (2006.01) A61K 47/48 (2006.01) C07K 14/47 (2006.01) C07K 16/18 (2006.01) C12N 1/19 (2006.01) C12N 1/21 (2006.01) C12N 5/10 (2006.01) C12P 21/08 (2006.01) C12Q 1/68 (2006.01) G01N 33/574 (2006.01) G01N 33/577 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2086829
2086829 9200757 PCTABS00010 The present invention is directed towards the diagnosis of malignant cancer by detection of the mts-1 mRNA or the mts-1 protein, encoded by the mts-1 gene. The present invention contemplates the use of recombinant mts-1 DNA and antibodies directed against the mts-1 protein to diagnose the metastatic potential of several types of tumor cells, including, for example, thyroid, epithelial, lung, liver and kidney tumor cells. The present invention is also directed to mammalian cell lines and tumors with high and low metastatic potential which have been developed to serve as useful model systems for in vitro and in vivo anti-metastasis drug screening.
Lukanidin Engene
Zain Sayeeda
Mcfadden Fincham
Research Corporation Technologies Inc.
LandOfFree
Diagnosis of metastatic cancer by the mts-1 gene does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Diagnosis of metastatic cancer by the mts-1 gene, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diagnosis of metastatic cancer by the mts-1 gene will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1775132